Bioterápico 200 DH causa redução do parasitismo cerebral em camundongos infectados com Toxoplasma gondii

Braga, Caroline Felicio; Falkowski, Gislaine Janaína Sanchez; Moreira, Neide Martins; Aleixo, Denise Lessa; de Araújo, Silvana Marques.
Int. j. high dilution res ; 10(36): 158-162, september 30, 2011.
Artículo en Inglés | LILACS-Express | ID: hom-10713

Documentos relacionados

  1. Factors Influencing Tissue Cyst Yield in a Murine Model of Chronic Toxoplasmosis.
  2. Polyether ionophore kijimicin inhibits growth of Toxoplasma gondii and controls acute toxoplasmosis in mice.
  3. MyosinA is a druggable target in the widespread protozoan parasite Toxoplasma gondii.
  4. Anti-<i>Toxoplasma gondii</i> screening of MMV pandemic response box and evaluation of RWJ-67657 efficacy in chronically infected mice.
  5. Infection of Mouse Neural Progenitor Cells by Toxoplasma gondii Reduces Proliferation, Migration, and Neuronal Differentiation in Vitro.
  6. The Impact of Helminth Coinfection on Innate and Adaptive Immune Resistance and Disease Tolerance during Toxoplasmosis.
  7. Direct evidence of cheetah (Acinonyx jubatus) as intermediate host of Toxoplasma gondii through isolation of viable strains.
  8. Cationic topical formulations tested in high dilutions offers protective effects in fibroblast cells culture
  9. Cationic topical formulations tested in high dilutions offers protective effects in fibroblast cells culture
  10. Functional analyses of Toxoplasma gondii dihydroorotase reveal a promising anti-parasitic target.